Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways. — Simone Boehrer (2007) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways.
Shared by
Guido Guido Kroemer
Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways.
Article
2007
en
Authors
+7 more
SB
Simone Boehrer
LA
Lionel Adès
LG
Lorenzo Galluzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
P057 Abrogation of the DNA-damage response in AML versus MDS cell lines
Simone Boehrer
,
Lionel Adès
,
Thorsten Braun
,
J. Grosjean
,
Catherine Fabre
,
Pierre Fenaux
,
Guido Guido Kroemer
Article
2006
Abrogation of the DNA-Damage Response in De Novo AML Versus MDS Cell Lines.
Simone Boehrer
,
Lionel Adès
,
Claire Fabre
,
Pierre Fenaux
,
Guido Guido Kroemer
Preprint
2024
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma
Panagiotis Malamos
,
Christina Papanikolaou
,
Maria Gavriatopoulou
,
Meletios A Dimopoulos
,
Evangelos Terpos
,
Vassilis L. Souliotis
Article
2024
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma
Panagiotis Malamos
,
Christina Papanikolaou
,
Maria Gavriatopoulou
,
Meletios A Dimopoulos
,
Evangelos Terpos
,
Vassilis L. Souliotis
Article
2011
Discovering the Epigenetic Modifications and the Alterations in Cellular DNA Damage Response Pathways That Drive Myelomagenesis; Clinical Implications Into the Biology of Multiple Myeloma
Μαρία Γκοτζαμανίδου
,
Evangelos Terpos
,
Petros P. Sfikakis
,
Meletios A Dimopoulos
,
Vassilis L. Souliotis
Discussion(0)
No comments yet. Be the first to comment.